{"id":"https://openalex.org/W2020508149","doi":"https://doi.org/10.1002/jps.10126","title":"Characterization of the interaction of 2\u2010hydroxypropyl\u2010\u03b2\u2010cyclodextrin with itraconazole at pH 2, 4, and 7","display_name":"Characterization of the interaction of 2\u2010hydroxypropyl\u2010\u03b2\u2010cyclodextrin with itraconazole at pH 2, 4, and 7","publication_year":2002,"publication_date":"2002-06-01","ids":{"openalex":"https://openalex.org/W2020508149","doi":"https://doi.org/10.1002/jps.10126","mag":"2020508149","pmid":"https://pubmed.ncbi.nlm.nih.gov/12115841"},"language":"en","primary_location":{"id":"doi:10.1002/jps.10126","doi":"https://doi.org/10.1002/jps.10126","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.10126","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030820978","display_name":"Jef Peeters","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jef Peeters","raw_affiliation_strings":["Department of Drug Delivery Research, Johnson & Johnson Pharmaceutical Research and Development, Beerse 2340, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Delivery Research, Johnson & Johnson Pharmaceutical Research and Development, Beerse 2340, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058099018","display_name":"Peter Neeskens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Neeskens","raw_affiliation_strings":["Department of Drug Delivery Research, Johnson & Johnson Pharmaceutical Research and Development, Beerse 2340, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Delivery Research, Johnson & Johnson Pharmaceutical Research and Development, Beerse 2340, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063691300","display_name":"Jan P. Tollenaere","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan P. Tollenaere","raw_affiliation_strings":["Department of Molecular Design & Chemoinformatics, Johnson & Johnson Pharmaceutical Research and Development, Beerse 2340, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Design & Chemoinformatics, Johnson & Johnson Pharmaceutical Research and Development, Beerse 2340, Belgium","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023165193","display_name":"Pieter Van Remoortere","orcid":"https://orcid.org/0000-0002-5537-5008","observed_orcids":["https://orcid.org/0000-0002-5537-5008"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pieter Van Remoortere","raw_affiliation_strings":["Department of Drug Delivery Research, Johnson & Johnson Pharmaceutical Research and Development, Beerse 2340, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Delivery Research, Johnson & Johnson Pharmaceutical Research and Development, Beerse 2340, Belgium","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109081047","display_name":"Marcus Eli Brewster","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Marcus E. Brewster","raw_affiliation_strings":["Department of Drug Delivery Research, Johnson & Johnson Pharmaceutical Research and Development, Beerse 2340, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Delivery Research, Johnson & Johnson Pharmaceutical Research and Development, Beerse 2340, Belgium","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5109081047"],"corresponding_institution_ids":[],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":5.2665,"has_fulltext":false,"cited_by_count":272,"citation_normalized_percentile":{"value":0.97297297,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"91","issue":"6","first_page":"1414","last_page":"1422"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10721","display_name":"Surfactants and Colloidal Systems","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hydroxypropyl-beta-cyclodextrin","display_name":"hydroxypropyl-\u03b2-cyclodextrin","score":0.9470000267028809},{"id":"https://openalex.org/keywords/itraconazole","display_name":"itraconazole","score":1.0},{"id":"https://openalex.org/keywords/host-guest-complexation","display_name":"host-guest complexation","score":0.8709999918937683},{"id":"https://openalex.org/keywords/ph-dependence","display_name":"pH dependence","score":0.7559999823570251},{"id":"https://openalex.org/keywords/stability-constants","display_name":"stability constants","score":0.6209999918937683},{"id":"https://openalex.org/keywords/solubility-isotherms","display_name":"solubility isotherms","score":0.8889999985694885},{"id":"https://openalex.org/keywords/protonation","display_name":"protonation","score":0.5270000100135803},{"id":"https://openalex.org/keywords/binding-sites","display_name":"binding sites","score":0.6800000071525574},{"id":"https://openalex.org/keywords/triazoles","display_name":"triazoles","score":0.628000020980835},{"id":"https://openalex.org/keywords/piperazine","display_name":"piperazine","score":0.6639999747276306},{"id":"https://openalex.org/keywords/molecular-modeling","display_name":"molecular modeling","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.8553686738014221},{"id":"https://openalex.org/C2777071850","wikidata":"https://www.wikidata.org/wiki/Q411229","display_name":"Itraconazole","level":3,"score":0.8431400656700134},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8268275260925293},{"id":"https://openalex.org/C30095370","wikidata":"https://www.wikidata.org/wiki/Q899488","display_name":"Protonation","level":3,"score":0.7132662534713745},{"id":"https://openalex.org/C2779433975","wikidata":"https://www.wikidata.org/wiki/Q40417805","display_name":"Cyclodextrin","level":2,"score":0.6532485485076904},{"id":"https://openalex.org/C2776201271","wikidata":"https://www.wikidata.org/wiki/Q409292","display_name":"Piperazine","level":2,"score":0.6133338212966919},{"id":"https://openalex.org/C178910836","wikidata":"https://www.wikidata.org/wiki/Q2196961","display_name":"Molecular model","level":2,"score":0.4475484788417816},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.39552104473114014},{"id":"https://openalex.org/C147597530","wikidata":"https://www.wikidata.org/wiki/Q369472","display_name":"Computational chemistry","level":1,"score":0.36296194791793823},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.31532177329063416},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.22935751080513},{"id":"https://openalex.org/C145148216","wikidata":"https://www.wikidata.org/wiki/Q36496","display_name":"Ion","level":2,"score":0.0},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000073738","descriptor_name":"2-Hydroxypropyl-beta-cyclodextrin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003505","descriptor_name":"Cyclodextrins","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008968","descriptor_name":"Molecular Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D047392","descriptor_name":"beta-Cyclodextrins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/jps.10126","doi":"https://doi.org/10.1002/jps.10126","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.10126","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:12115841","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12115841","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W279088417","https://openalex.org/W287828772","https://openalex.org/W625323494","https://openalex.org/W1498305210","https://openalex.org/W1522767714","https://openalex.org/W1965196524","https://openalex.org/W1982747519","https://openalex.org/W1992053087","https://openalex.org/W1993267893","https://openalex.org/W2012890278","https://openalex.org/W2021321721","https://openalex.org/W2025544916","https://openalex.org/W2036406575","https://openalex.org/W2043527252","https://openalex.org/W2044594845","https://openalex.org/W2046017608","https://openalex.org/W2054088584","https://openalex.org/W2055091943","https://openalex.org/W2056675508","https://openalex.org/W2069193583","https://openalex.org/W2079261282","https://openalex.org/W2083397462","https://openalex.org/W2085792620","https://openalex.org/W2087265784","https://openalex.org/W2092094897","https://openalex.org/W2100358013","https://openalex.org/W2101171473","https://openalex.org/W2127205020","https://openalex.org/W2130703786","https://openalex.org/W2170290676","https://openalex.org/W2313836793","https://openalex.org/W2463371479","https://openalex.org/W2760976281","https://openalex.org/W2813718079","https://openalex.org/W2931933173","https://openalex.org/W4237777089"],"related_works":["https://openalex.org/W1972093980","https://openalex.org/W1982747519","https://openalex.org/W2102235525","https://openalex.org/W2356360218","https://openalex.org/W2149050996","https://openalex.org/W2363558038","https://openalex.org/W2904528597","https://openalex.org/W7000147310","https://openalex.org/W7163710439","https://openalex.org/W2610595044"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":18},{"year":2012,"cited_by_count":18}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}